Personalis

Personalis is a contract research organization that offers genome-scale diagnostics services for cancer and inherited genetic diseases. Read more

1,492 Followers on Owler
1,492 Followers on Owler
1,492 Followers on Owler
1,492 Followers on Owler

Personalis

Personalis is a contract research organization that offers genome-scale diagnostics services for cancer and inherited genetic diseases. Read more

John West's photo - CEO of Personalis

CEO

John West

CEO Approval Rating

98/100

Founded:

2011

Status:

PublicIndependent CompanyNASDAQPSNL

PERSONALIS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

NanoString is seen as one of Personalis's biggest rivals. NanoString is headquartered in Seattle, Washington, and was founded in 2003. Like Personalis, NanoString also works within the Biotechnology sector. NanoString generates 152% the revenue of Personalis.

PGDx is seen as one of Personalis's top competitors. PGDx was founded in 2010, and its headquarters is in Baltimore, Maryland. PGDx operates in the Biotechnology industry. PGDx has 34 fewer employees than Personalis.

Adaptive Biotechnologies is one of Personalis's top rivals. Adaptive Biotechnologies is a Public company that was founded in Seattle, Washington in 2009. Adaptive Biotechnologies operates in the Biotechnology industry. Adaptive Biotechnologies has 388 more employees vs. Personalis.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Quest Diagnostics a competitor of Personalis?

Personalis Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$80.4M

Personalis's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 882.3M. Over the last four quarters, Personalis's revenue has grown by 7.1%. Specifically, in Q1 2021's revenue was $20.9M; in Q4 2020, it was $20.2M; in Q3 2020, it was $19.8M; in Q2 2020, Personalis's revenue was $19.5M.

Personalis Acquisitions

No recent acquisitions found related to Personalis

Personalis Funding History

Since Personalis was founded in 2011, it has participated in 5 rounds of funding. In total Personalis has raised $203.6M. Personalis' last funding round was on Jun 2019 for a total of $134.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 2019
$134.7M

Debt
Jun 2017
$12.2M
-
Series C
Dec 2014
$29.6M
Series B
Sep 2013
$22.1M
Series A
Aug 2011
$5M
-

Since Personalis was founded in 2011, it has participated in 5 rounds of funding. In total Personalis has raised $203.6M. Personalis' last funding round was on Jun 2019 for a total of $134.7M

Personalis Investments

No recent investments found related to Personalis

Personalis News

April 28, 2021Zacks

Personalis (PSNL) Q1 Earnings Expected to Decline

Personalis (PSNL) doesn't possess the right combination of the two key ingredients for a likely earni... See more »
April 8, 2021MarketScreener

Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform

(marketscreener.com) Personalis, Inc. , a leader in advanced genomics for cancer, today announced tha... See more »
March 9, 2021MarketScreener

Announces Changes to its Board of Directors

(marketscreener.com) Personalis, Inc. , a leader in advanced genomics for population sequencing and c... See more »
February 24, 2021MarketScreener

Neoantigen-based Cancer Therapies

(marketscreener.com) Neoantigen-based Cancer Therapies Christelle Johnson, MS, PhD Senior Field Appli... See more »
February 24, 2021MarketScreener

Comprehensive Immunogenomics Profiling for the Discovery of the Next Generation of Oncology Biomarkers

(marketscreener.com) Comprehensive Immunogenomics Profiling for the Discovery of the Next Generation ... See more »

Personalis Blogs

November 24, 2020Personalis, Inc. Blog

2020 SITC: Precision neoantigen discovery using novel algorithms and expanded HLA-ligandome datasets

2020 SITC: Precision neoantigen discovery using novel algorithms and expanded HLA-ligandome datasets ... See more »
November 24, 2020Personalis, Inc. Blog

2020 SITC: Profiling tumor circulating cell-free DNA with an enhanced whole-exome to enable sensitive assessment of somatic mutations

2020 SITC: Profiling tumor circulating cell-free DNA with an enhanced whole-exome to enable sensitive... See more »
November 24, 2020Personalis, Inc. Blog

2020 SITC: B-cell receptor heavy chain repertoire profiling using an augmented transcriptome

2020 SITC: B-cell receptor heavy chain repertoire profiling using an augmented transcriptome Comprehe... See more »
November 24, 2020Personalis, Inc. Blog

2020 SITC: Orthogonally and functionally validated algorithm for detecting HLA loss of heterozygosity

2020 SITC: Orthogonally and functionally validated algorithm for detecting HLA loss of heterozygosity... See more »
November 3, 2020Personalis, Inc. Blog

Comprehensive Immunogenomics Profiling for the Discovery of the Next Generation of Oncology Biomarkers

Christelle Johnson, MS, PhD Senior Field Applications Scientist Cancer Genomics & Immuno-Oncology... See more »
October 6, 2020Personalis, Inc. Blog

SHERPA™ Bioinformatics Engine

SHERPA™ Bioinformatics Engine Systematic HLA Epitope Ranking Pan Algorithm Technologies for neoa... See more »
August 29, 2020Personalis Blog

Unlock the power of DNA

Powered by our ACE Technology, our DNA Assays provide more uniform coverage at high depths than stand... See more »

Personalis Press Releases

April 21, 2021Business Wire

Personalis to Report First Quarter 2021 Financial Results on May 5, 2021

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f... See more »
February 16, 2021Business Wire

Personalis to Present at Upcoming Investor Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f... See more »
February 12, 2021Business Wire

Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f... See more »
February 4, 2021Business Wire

Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f... See more »
November 18, 2020Business Wire

Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event

MENLO PARK, Calif.--(BUSINESS WIRE)-- #EACR--Personalis, Inc. to Present at EACR Liquid Biopsies Virt... See more »
November 9, 2020Business Wire

Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

MENLO PARK, Calif.--(BUSINESS WIRE)-- #PrecisionOncology--Personalis, Inc. to Present New Data at the... See more »
November 5, 2020Business Wire

Personalis Reports Third Quarter 2020 Financial Results

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics f... See more »

Personalis Videos

Social Media

Personalis Headquarters

1330 O’Brien Drive

Menlo Park, California94025

650-752-1300

Driving Directions »

Trending Companies

Personalis Summary

ABOUT

Overview

Personalis is a contract research organization that offers genome-scale diagnostics services for cancer and inherited genetic diseases. Personalis was founded in 2011. Personalis' headquarters is located in Menlo Park, California, USA 94025. It has ra...

CEO

Personalis's CEO, John West, currently has an approval rating of 98%. Personalis's primary competitors are NanoString, PGDx & Adaptive Biotechnologies.

Website

personalis.com

Frequently Asked Questions about Personalis

  1. When was Personalis founded?

    Personalis was founded in 2011
  2. Who is Personalis's CEO?

    Personalis's CEO is John West
  3. How much revenue does Personalis generate?

    Personalis generates $80.4M in revenue
  4. How much funding does Personalis have?

    Personalis has historically raised $203.6M in funding
  1. Where is Personalis's headquarters?

    Personalis's headquarters is in Menlo Park California, USA
  2. How many employees does Personalis have?

    Personalis has 234 employees
  3. What sector does Personalis operate in?

    Personalis is in Biotechnology
  4. Who are Personalis's competitors?

    Personalis's top competitors are NanoString, PGDx, Adaptive Biotechnologies